Artis Ventures
ActiveOverview
Artis Ventures is a San Francisco-based venture capital firm founded in 2001 that invests in early-stage companies at the intersection of technology and biology, known as TechBio.123 It focuses on biotech, healthcare, life sciences, and related sectors, managing multiple funds including recent ones like Artis TechBio Select I opened in April 2024.1 The firm is noted for coining and trademarking the term 'TechBio' and building a network of healthcare pioneers for guidance.24
History
Artis Ventures was founded in 2001 by Stuart Peterson, who serves as Managing Partner.14 It has managed at least four closed funds, with the most recent Artis TechBio II closing in December 2023, and one fund in market as of 2024.1 The firm shifted emphasis to TechBio investments, backing platform companies in technology-biology convergence.23
Notable Products
- Artis TechBio Select I - Fund opened April 2024 targeting TechBio investments.
- Artis TechBio II - Fund closed December 2023 focused on technology and biology.
Reputation
Artis Ventures is recognized among investors for pioneering TechBio investments and early high-conviction bets on platform companies.2 Professionals note its network of biotech and healthcare executives as a strength for portfolio guidance.4 Specific criticisms are not detailed in available sources.